Rocuronium bromide
- CAS No.
- 119302-91-9
- Chemical Name:
- Rocuronium bromide
- Synonyms
- Esmeron;Zemuron;1-[17B-(acetyloxy)-3a-hydroxy-2B-(4-morpholinyl)-;1-[(2b,3a,5a,16b,17b)-17-(Acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl]-1-(2-propenyl)pyrrolidinium Bromide;Rocuronium Bromide／1-[17B-(acetyloxy)-3a-hydroxy2B-(4-morpholinyl)-5a-androstan-16B-yl]-1-(2-propenyl)pyrrolidinium bromide;Eslax;Org-9426;Esmeron：Zemuron;ROCURONIUM BROMIDE;ROCURONIUN BROMIDE
- CBNumber:
- CB2222507
- Molecular Formula:
- C32H53BrN2O4
- Molecular Weight:
- 609.68
- MOL File:
- 119302-91-9.mol
- MSDS File:
- SDS
- Modify Date:
- 2024/4/29 14:28:21
| Melting point | 162-1640C |
|---|---|
| alpha | D20 +18.7° (c = 1.03 in CHCl3) |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | H2O: soluble100mg/mL, clear, light yellow |
| form | Powder to Crystal |
| color | White to Yellow |
| Merck | 14,8246 |
| Stability | Hygroscopic |
| InChIKey | OYTJKRAYGYRUJK-FMCCZJBLSA-M |
| CAS DataBase Reference | 119302-91-9(CAS DataBase Reference) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS06 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H331-H312-H302-H330 | |||||||||
| Precautionary statements | P261-P271-P304+P340-P311-P321-P403+P233-P405-P501-P280-P302+P352-P312-P322-P363-P501-P260-P271-P284-P304+P340-P310-P320-P403+P233-P405-P501-P264-P270-P301+P312-P330-P501 | |||||||||
| WGK Germany | 3 | |||||||||
| HS Code | 2934990002 | |||||||||
| NFPA 704 |
|
Rocuronium bromide price More Price(4)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich(India) | R5155 | Rocuronium bromide ≥97% (perchloric acid titration) | 119302-91-9 | 50MG | ₹8454.33 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | R5155 | Rocuronium bromide ≥97% (perchloric acid titration) | 119302-91-9 | 250MG | ₹25731.03 | 2022-06-14 | Buy |
| Sigma-Aldrich(India) | PHR2397 | Rocuronium Bromide Pharmaceutical Secondary Standard; Certified Reference Material | 119302-91-9 | 500MG | ₹17850.43 | 2022-06-14 | Buy |
| TCI Chemicals (India) | R0099 | Rocuronium Bromide | 119302-91-9 | 100MG | ₹5500 | 2022-05-26 | Buy |
Rocuronium bromide Chemical Properties,Uses,Production
Chemical Properties
Off-white Solid
Uses
Aminosteroid, competitive neuromuscular blocker
Description
Rocuronium bromide is a short-acting nondepolarizing steroidal neuromuscular blocker introduced in the U.S.A as Zemuron and in the United Kingdom as Esmeron. k is indicated for use as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Rocuroniurn bromide has a significantly more rapid onset than other intermediate acting neuromuscular blockers, comparable to succinylcholine but with a very stable cardiovascular profile and has an improved side effect profile. It has been reported that good to excellent intubation conditions were achieved only one minute after a bolus dose of 600μg/kg of rocuronium bromide. It has a short duration of action, therefore, is useful for rapid sequence intubation without unacceptable delays in the spontaneous recovery of neuromuscular function.
Definition
ChEBI: Rocuronium bromide is the organic bromide salt of a 5alpha androstane compound having 3alpha-hydroxy-, 17beta-acetoxy-, 2beta-morpholino- and 16beta-N-allyllyrrolidinium substituents. It has a role as a neuromuscular agent and a muscle relaxant. It is an organic bromide salt and a quaternary ammonium salt. It contains a rocuronium. It derives from a hydride of a 5alpha-androstane.
Biological Functions
Rocuronium bromide (Zemuron) is a recently approved amino steroid neuromuscular blocking agent. It has a rapid onset of action (1 minute), but its duration of action is intermediate (55 minutes), about that of vecuronium. On rare occasions, it may release histamine and cause cardiac irregularities. Rapacuronium bromide (Raplon) is the most recent neuromuscular blocking agent approved by the United States Food and Drug Administration (FDA). It is an analogue of vecuronium and is thus categorized as an amino steroid. It has a rapid onset of action (1.5 minutes) and a short to intermediate duration of action (20 minutes).This makes it a suitable alternative to mivacurium or succinylcholine for short procedures. It is eliminated mainly by the liver.Adverse effects are dose dependent; they include tachycardia, hypotension, and bronchospasm. These effects may be related to the ability of the drug to release a small amount of histamine.
Side effects
Common side effects of Rocuronium bromide include anaphylactic reactions, residual neuromuscular weakness, critical illness myopathy and polyneuropathy. Systemic anaphylactic reactions should be suspected in any patient who develops sudden cardiovascular collapse with cutaneous signs of anaphylactic reaction after Rocuronium bromide administration. Adverse effects of residual neuromuscular blockade have been shown to increase postoperative morbidity and mortality. The inability to fully reverse the effects of neuromuscular blockade may result in an increased risk of postoperative respiratory dysfunction, including hypoxia, need for mechanical ventilation, and increased length of hospital stay. Prolonged infusion of neuromuscular blockade may prolong skeletal muscle weakness due to myopathy caused by critical illness, in patients on steroids or with multiple organ failure. Rocuronium bromide has been shown to be very stable and has no effect on heart rate or blood pressure.
Safety
Limited information on the use of rocuronium during breastfeeding indicates that no adverse infant effects occur. Because it is short acting, highly polar and poorly absorbed orally, it is not likely to reach the breastmilk in high concentration or to reach the bloodstream of the infant. When a combination of anesthetic agents is used for a procedure, follow the recommendations for the most problematic medication used during the procedure. General anesthesia for cesarean section using rocuronium as a component may delay the onset of lactation.
Rocuronium bromide Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | Inquiry |
|---|---|---|---|---|---|
| Viruj Pharmaceuticals Pvt Ltd | +91-9441591589 +91-9441591589 | Hyderabad, India | 33 | 58 | Inquiry |
| SEUTIC | +91-8309787199 +91-8309787199 | Hyderabad, India | 124 | 58 | Inquiry |
| Prajna generics pvt ltd | +91-9441174873 +91-9441174873 | Hyderabad, India | 24 | 58 | Inquiry |
| Sintilla Medcoms Pvt Ltd | +91-4027808001 +91-8886733867 | Telangana, India | 307 | 58 | Inquiry |
| Gland Chemicals Pvt Ltd | +91-9492733833 +91-9346729196 | Telangana, India | 16 | 58 | Inquiry |
| Ralington Pharma | +91-7948911722 +91-9687771722 | Gujarat, India | 1350 | 58 | Inquiry |
| Gland Pharma Ltd | +91-7075736524 +91-9700602423 | Telangana, India | 44 | 58 | Inquiry |
| Surajlok Chemicals Pvt Ltd (Neon Laboratories Ltd) | +91-2268107000 +91-9987232509 | Maharashtra, India | 30 | 58 | Inquiry |
| Synnat Pharma Pvt Ltd | +91-9966980001 +91-9989984964 | AndhraPradesh, India | 22 | 58 | Inquiry |
| A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
| Supplier | Advantage |
|---|---|
| Viruj Pharmaceuticals Pvt Ltd | 58 |
| SEUTIC | 58 |
| Prajna generics pvt ltd | 58 |
| Sintilla Medcoms Pvt Ltd | 58 |
| Gland Chemicals Pvt Ltd | 58 |
| Ralington Pharma | 58 |
| Gland Pharma Ltd | 58 |
| Surajlok Chemicals Pvt Ltd (Neon Laboratories Ltd) | 58 |
| Synnat Pharma Pvt Ltd | 58 |
| A.J Chemicals | 58 |
119302-91-9(Rocuronium bromide)Related Search:
1of4
chevron_right